Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pavle Kuparadze, Avtandil DolidzefiledCriticalPavle Kuparadze
Priority to GEAU19963033UpriorityCriticalpatent/GEU1997243Y/en
Publication of GEU1997243YpublicationCriticalpatent/GEU1997243Y/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
This utility model refers to pharmacology and concerns the means for treatment of benigh tumors and precancer diseases of the skin. The technical result of the utility model is in widening the assortment of medicinal prepara¬tions, in increasing the medicinal pro¬perties. The medicinal means comprises components in following relation (mass%): nitric acid copper 63-72 lactic acid 25-34 novocain 1,5-3,0 salicylic acid 0,5-1,5
GEAU19963033U1996-01-291996-01-29Means for Treatment of Benign Tumors and Precancer Diseases of the Skin
GEU1997243Y
(en)
Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic phosphate, 8-aminoadenosine 3',5'-cyclic phosphate and preparation thereof.